EVLO

Evelo Biosciences News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Evelo Biosciences Inc EVLO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -1.75% 2.81 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.87 2.71 2.96 2.81 2.86
more quote information »

Recent News

Date Time Source Heading
8/05/202206:00GLOBEEvelo Biosciences to Announce Second Quarter 2022 Financial..
7/18/202216:23EDGARInitial Statement of Beneficial Ownership (3)
7/18/202207:47EDGARCurrent Report Filing (8-k)
7/18/202206:00GLOBEEvelo Biosciences Announces Appointment of Marella Thorell..
7/01/202206:59EDGARCurrent Report Filing (8-k)
7/01/202206:32EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/30/202216:53EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:48EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:45EDGARStatement of Changes in Beneficial Ownership (4)
6/13/202216:42EDGARStatement of Changes in Beneficial Ownership (4)
6/09/202217:08EDGARCurrent Report Filing (8-k)
6/01/202219:01EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202219:01EDGARInitial Statement of Beneficial Ownership (3)
6/01/202216:13EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202207:40EDGARCurrent Report Filing (8-k)
5/31/202216:12EDGARStatement of Changes in Beneficial Ownership (4)
5/31/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
5/25/202208:37GLOBEEvelo Biosciences Announces $79.2 Million Registered Direct..
5/25/202208:32EDGARCurrent Report Filing (8-k)
5/13/202209:47TRMNBMO Capital Thinks Evelo Biosciences’ Stock is Going to..
5/12/202210:46GLOBECORRECTION: Evelo Biosciences Announces First Quarter 2022..
5/12/202208:06EDGARCurrent Report Filing (8-k)
5/12/202206:00GLOBEEvelo Biosciences Announces First Quarter 2022 Financial..
5/02/202216:04EDGARStatement of Changes in Beneficial Ownership (4)
4/26/202216:34EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/21/202206:00GLOBEEvelo Biosciences Appoints John Maraganore, Ph.D. and Tassos..
4/14/202216:18EDGARCurrent Report Filing (8-k)
4/14/202206:00GLOBEEvelo Biosciences Provides Updated Guidance on Advancing..
4/06/202206:00GLOBEEvelo Biosciences Announces Appointments of Jose-Carlos..
4/05/202217:42EDGARStatement of Changes in Beneficial Ownership (4)
4/05/202217:37EDGARInitial Statement of Beneficial Ownership (3)
4/05/202217:32EDGARStatement of Changes in Beneficial Ownership (4)
4/05/202217:23EDGARCurrent Report Filing (8-k)
4/01/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
3/26/202212:00GLOBEEvelo Biosciences Presents Late-Breaking Oral Abstract on..
3/25/202211:06TRMNBMO Capital Sticks to Their Buy Rating for Evelo Biosciences..
3/25/202207:35TRMNChardan Capital Thinks Evelo Biosciences’ Stock is Going to..
3/24/202217:18EDGARAnnual Report (10-k)
3/24/202212:26SEEKEvelo Biosciences spikes after 4Q 2021 earnings
3/24/202207:19EDGARCurrent Report Filing (8-k)
3/24/202206:01SEEKEvelo Biosciences GAAP EPS of -$0.54 beats by $0.08
3/24/202206:00GLOBEEvelo Biosciences Announces Fourth Quarter and Full Year..
3/17/202207:00GLOBEEvelo Biosciences to Report Fourth Quarter and Full Year..
3/07/202206:00GLOBEEvelo Biosciences to Host KOL Discussion on Treatment..
3/02/202207:00GLOBEEvelo Biosciences to Participate in Cowen 42nd Annual Health..
2/28/202209:00PRNUSAlltrna Appoints Rare Disease Clinical Research Expert, Dr...
2/28/202207:52SEEKEvelo psoriasis therapy EDP1815 shows durable response in..
2/28/202207:46EDGARCurrent Report Filing (8-k)
2/28/202206:00GLOBEDurable and Deepening Clinical Responses Observed in..
2/17/202208:42SEEKEvelo Biosciences begins dosing in phase 2 trial of EDP1815..


Your Recent History
NASDAQ
EVLO
Evelo Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now